https://doi.org/10.1016/j.apsb.2021.01.001
X
Xiangjin Zheng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
42
Papers
2.4K
Citations
23
h-index
27
i10-index
Xiangjin Zheng is an academic researcher from Chinese PLA General Hospital. The author has contributed to research in topics: Ferroptosis and cancer prognosis & Cancer, Lipids, and Metabolism & MicroRNA in disease regulation. The author has an h-index of 23, co-authored 36 publications.
Papers by this author
worksThe biology, function, and applications of exosomes in cancer
2021 · Acta Pharmaceutica Sinica B · 517 citations
miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway
2018 · Clinical Epigenetics · 78 citations
https://doi.org/10.1186/s13148-018-0495-y
3-O-acetyl-11-keto-β-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2/M phase
2018 · Journal of Experimental & Clinical Cancer Research · 71 citations
https://doi.org/10.1186/s13046-018-0805-4
Sphingosine kinase 1 promotes growth of glioblastoma by increasing inflammation mediated by the NF-κB /IL-6/STAT3 and JNK/PTX3 pathways
2022 · Acta Pharmaceutica Sinica B · 62 citations
https://doi.org/10.1016/j.apsb.2022.09.012
Author Correction: Benzimidazoles induce concurrent apoptosis and pyroptosis of human glioblastoma cells via arresting cell cycle
2022 · Acta Pharmacologica Sinica · 4 citations
https://doi.org/10.1038/s41401-022-00971-x
Correction: MELK is an oncogenic kinase essential for metastasis, mitotic progression, and programmed death in lung carcinoma
2024 · Signal Transduction and Targeted Therapy · 1 citations
https://doi.org/10.1038/s41392-024-01910-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat